The New Frontier of Physician Reimbursement Reform
This week in healthcare, ASCO and COA release a joint statement setting forth ambitious goals for oncology-related reimbursement reform.
Principles to Guide the Evolution of Health Care Payment Systems that Support High-Quality, High-Value Cancer Care [PDF]
In a joint statement, the American Society of Clinical Oncology (ASCO) and the Community Oncology Alliance (COA) issued a list of six principles as a “joint statement on payment models that support high-quality, high-value cancer care.”
The above statement came at the conclusion of a long-running, five-part series on physician payment reform that has been written and published by ASCO. The series gives a thorough background on the issues surrounding physician payment reform.
Part 1: Oncology Practice: Front and Center in National Payment Reform Debate
Part 2: Sustainable Growth Rate: An Outdated Prescription for Medicare Payment
Part 3: Physician Administered Drugs — The Evolution of Buy and Bill
Part 4: Payment Reform Models Explained
Part 5: A Proposal for Patient-Centered Payment Reform
There have been signs in both houses of Congress that the SGR — “sustainable growth rate” — may soon be repealed. This Q-and-A piece explores Congress’s proposals as well as the potential effects of reform on both doctors and patients.
This author argues that, while a shorter (March 31st) SGR-patch renewal by Congress might signal that a larger fix is imminent, the piled-up cost of cumulative delays might prove a roadblock.
Want more health care landscape updates and insights? Follow us on Twitter @innovpartners.